Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 20.17
(-0.93%)
CNY 20.17
(-0.93%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 661.58 Thousand CNY | -60.26% |
| 2022 | 1.66 Million CNY | 5.17% |
| 2021 | 1.58 Million CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 661.58 Thousand CNY | 0.0% |
| 2024 Q2 | 4.04 Million CNY | 0.0% |
| 2024 Q3 | 11.18 Million CNY | 202.72% |
| 2023 Q3 | 1.75 Million CNY | 63.89% |
| 2023 Q1 | 2.5 Million CNY | 50.63% |
| 2023 Q4 | 661.58 Thousand CNY | -62.26% |
| 2023 FY | 661.58 Thousand CNY | -60.26% |
| 2023 Q2 | 1.06 Million CNY | -57.35% |
| 2022 Q3 | 1.92 Million CNY | 17.22% |
| 2022 FY | 1.66 Million CNY | 5.17% |
| 2022 Q1 | 1.61 Million CNY | 2.1% |
| 2022 Q4 | 1.66 Million CNY | -13.37% |
| 2022 Q2 | 1.63 Million CNY | 1.43% |
| 2021 FY | 1.58 Million CNY | 0.0% |
| 2021 Q4 | 1.58 Million CNY | 0.0% |
| 2021 Q3 | - CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |